Clarke Atwell is the President and CEO of Claris Biotherapeutics, Inc. a biotechnology company focused on developing novel therapies for the treatment of diseases with high unmet needs in ophthalmology. This is the second company founded in Jersey City by Clarke. Clarke is a seasoned international biopharmaceutical executive with experience in company foundation, leadership and the licensing of products and technologies. Proven ability to build, lead and rapidly integrate diverse organizations. Extensive experience in the development of products from concept through to Phase III, in multiple disease areas. Successful history of launching novel therapies, managing mature products and maximizing profitability of product portfolios.